A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
Active, not recruiting · NCT07221162 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 1 | 2026-06-23 | NCT07221162 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 402 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Center for Immunization Research, Johns Hopkins Bloomberg School Public Health | Baltimore | United States | 1 |
| Duke Vaccine and Trials Unit | Durham | United States | 12 |
| Kaiser Permanente Washington Health Research Institute | Seattle | United States | 1 |
| Saint Louis University Center for Vaccine Development | St Louis | United States | 3 |
| University of California San Francisco - Zuckerberg San Francisco General Hospital - Division of Human Immunodeficiency Virus, Infectious Disease, and Global Medicine | San Francisco | United States | 1 |
| University of Pittsburgh - Medicine - Infectious Diseases | Pittsburgh | United States | 1 |
| University of Rochester Medical Center - Vaccine Research Unit | Rochester | United States | 1 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |